Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CYTEIR-THERAPEUTICS-INC-123863828/news/Cyteir-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-Combination-Trial-With-CYT-0851-37538369/?utm_source=whatsapp&utm_medium=social&utm_campaign=share